Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released May 10, 2017, during market hours
10-Q filed May 10, 2017, 40 days after period end · 0001171843-17-002892
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $2.50K | $2.50K | $2.92K | $4.17K |
| Net Income | -$7.57M | -$6.61M | -$5.05M | -$5.92M |
| EPS Diluted | -$0.68 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.93 |
| -$0.06 |
| -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
